FDA Inspection 1069144 — Anzai Medical Co., Ltd.
The FDA completed an inspection of Anzai Medical Co., Ltd. on July 26, 2018 in Shinagawa. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Shinagawa (Japan)